| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,310,000,000 |
| Market
Cap: |
75.35(B) |
| Last
Volume: |
13,973,164 |
Avg
Vol: |
7,738,395 |
| 52
Week Range: |
$54.91 - $81.42 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Retail |
| Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : 10.7 |
| Insider 6 Months : 10.7 |
| Insider 3/6 Months : 21.5 |
|
| Guru Rank Number : 214 |
| Guru Rank Value : 5.7 |
| Guru Occurances : 5 |
|
|
|
|
|
| |
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
10,181 |
10,181 |
12,181 |
26,181 |
| Total Buy Value |
$554,173 |
$554,173 |
$695,103 |
$1,671,670 |
| Total People Bought |
2 |
2 |
2 |
3 |
| Total Buy Transactions |
2 |
2 |
3 |
4 |
| Total Shares Sold |
29,473 |
29,473 |
55,232 |
484,338 |
| Total Sell Value |
$2,267,947 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
| Total People Sold |
1 |
1 |
2 |
5 |
| Total Sell Transactions |
1 |
1 |
2 |
7 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bertolini Mark T |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$116,211 |
D/D |
2,222 |
12,222 |
|
- |
|
| Aguirre Fernando |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$116,211 |
D/D |
2,222 |
18,444 |
|
- |
|
| Bracken Richard M |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$121,859 |
D/D |
2,330 |
13,722 |
|
- |
|
| Ludwig Edward J |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$121,859 |
D/D |
2,330 |
9,708 |
|
- |
|
| Dorman David W |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$292,462 |
D/D |
5,592 |
127,894 |
|
- |
|
| Swift Richard J |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$125,625 |
D/D |
2,402 |
5,660 |
|
- |
|
| Millon Jean Pierre |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$116,211 |
D/D |
2,222 |
2,222 |
|
- |
|
| Finucane Anne A. |
Director |
• • – |
2019-05-16 |
4 |
A |
$52.30 |
$116,211 |
D/D |
2,222 |
2,222 |
|
- |
|
| Merlo Larry J |
President and CEO |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$1,130,295 |
D/D |
(20,858) |
388,784 |
|
- |
|
| Hourican Kevin |
EVP & President, CVS Pharmacy |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$60,097 |
D/D |
(1,109) |
15,237 |
|
- |
|
| Flum Joshua Matthew |
EVP, Corp Strategy & Bus Dev |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$40,209 |
D/D |
(742) |
18,460 |
|
- |
|
| Bisaccia Lisa |
EVP and Chief HR Officer |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$130,652 |
D/D |
(2,411) |
30,942 |
|
- |
|
| Moriarty Thomas M |
EVP & General Counsel |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$262,117 |
D/D |
(4,837) |
43,287 |
|
- |
|
| Boratto Eva C |
EVP & CFO |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$72,398 |
D/D |
(1,336) |
46,421 |
|
- |
|
| Brennan Troyen A |
EVP and Chief Medical Officer |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$195,409 |
D/D |
(3,606) |
84,317 |
|
- |
|
| Lotvin Alan |
EVP, Transformation |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$46,766 |
D/D |
(863) |
7,578 |
|
- |
|
| Clark James David |
SVP, Cont & Chief Acct Officer |
• • – |
2019-04-01 |
4 |
D |
$54.19 |
$13,710 |
D/D |
(253) |
9,135 |
|
- |
|
| Clark James David |
SVP, Cont & Chief Acct Officer |
• • – |
2019-04-01 |
4 |
A |
$54.19 |
$299,996 |
D/D |
5,536 |
13,793 |
|
- |
|
| Brown C David II |
Director |
• • – |
2019-03-11 |
4 |
B |
$53.18 |
$531,800 |
D/D |
10,000 |
111,252 |
2.39 |
- |
|
| Aguirre Fernando |
Director |
• • – |
2019-03-11 |
4 |
B |
$53.59 |
$101,821 |
D/D |
1,900 |
16,222 |
2.39 |
- |
|
| Ludwig Edward J |
Director |
• • – |
2019-03-08 |
4 |
B |
$52.80 |
$105,600 |
D/D |
2,000 |
7,378 |
2.39 |
- |
|
| Dorman David W |
Director |
• • – |
2019-03-08 |
4 |
B |
$52.71 |
$506,016 |
D/D |
9,600 |
122,302 |
2.39 |
- |
|
| Aguirre Fernando |
Director |
• • – |
2019-03-01 |
4 |
B |
$58.29 |
$198,769 |
D/D |
3,410 |
14,322 |
2.39 |
- |
|
| Ludwig Edward J |
Director |
• • – |
2019-03-01 |
4 |
B |
$58.27 |
$233,080 |
D/D |
4,000 |
5,378 |
2.39 |
- |
|
| Clark James David |
SVP, Cont & Chief Acct Officer |
• • – |
2019-03-01 |
4 |
OE |
$45.07 |
$74,996 |
D/D |
1,664 |
8,557 |
|
- |
|
711 Records found
|
|
Page 14 of 29 |
|
|
1.26 (2.24%) 
